Several down, a few to go: histamine H₃ receptor ligands making the final push towards the market?

Author： Kuhne Sebastiaan Wijtmans Maikel Lim Herman D Leurs Rob de Esch Iwan JP

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.12, 2011-12, pp. : 1629-1648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in histamine H₃/H₄ receptor ligands

By Stark Holger

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 851-865

Informa Healthcare

Access to resources Recommend Favorite

Histamine H3 Receptor Function and Ligands: Recent Developments

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 47-57

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H₃ receptor antagonists

By Tozer M.J. Kalindjian S.B.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1045-1055

Informa Healthcare

Access to resources Recommend Favorite

Histamine H3 Receptor Agonists

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-11 ,pp. : 955-963

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo modulation of rat hypothalamic histamine release by the histamine H 3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application

By Jansen F.P. Mochizuki T. Yamamoto Y. Timmerman H. Yamatodani A.

European Journal of Pharmacology, Vol. 362, Iss. 2, 1998-12 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite